Communication Is Key: Why Self-Advocacy Matters in AML Care
https://vimeo.com/1195986359 Clear communication can make a meaningful difference during AML treatment. Dr. Anand Patel, an AML specialist, explains why patients should never hesitate to report symptoms, ask questions, or speak…
Understanding MRD and Its Impact on AML Care
https://vimeo.com/1195986290 What is measurable residual disease (MRD), and why does it matter in AML care? Hematologist-oncologist Dr. Anand Patel explains how this advanced testing can detect tiny amounts of leukemia…
AML Treatment and Care Choices | The Role of Test Results
https://vimeo.com/1195986291 AML treatment options are expanding, giving patients more personalized approaches than ever before. AML specialist Dr. Anand Patel explains the differences between intensive chemotherapy and newer lower-intensity therapies, and…
Understanding AML Risk Categories and Why They Matter
https://vimeo.com/1195986292 What does it mean to have “favorable,” “intermediate,” or “adverse” risk AML, and how do those classifications affect treatment decisions? Hematologist-oncologist Dr. Anand Patel explains how in-depth test results…
Key Questions to Ask Your Doctor About AML Care and Treatment
https://vimeo.com/1195986469 An AML diagnosis can bring uncertainty and difficult decisions. Dr. Anand Patel, an AML specialist, shares the essential questions every patient and care partner should ask after diagnosis, particularly…
Advances in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia (AML)
AML expert Dr. Omer Jamy discusses his approach when considering treatment for patients with relapsed or refractory AML, including transplant eligibility, molecular markers, and whether clinical trials may be an…
What Is the AGILE Study? Research for AML Patients With the IDH1 Mutation
https://vimeo.com/841012970 AML expert Dr. Omer Jamy reviews the results of the AGILE study, a clinical trial evaluating the efficacy and safety of ivosidenib + azacitidine vs placebo + azacitidine in…
Expert Advice | Shining a Light on Equitable AML Care
https://vimeo.com/825226188 While treatment options are improving, there are still many factors impacting equitable care for AML patients. Dr. Ann-Kathrin Eisfeld shares advice for improving research and clinical trials for underserved…
Emerging AML Treatment Classes Showing Promise
https://vimeo.com/825225712 What therapies are in development for acute myeloid leukemia (AML)? Dr. Ann-Kathrin Eisfeld discusses the latest research for AML treatment, including menin inhibitors and CAR T-cell therapy. Dr. Ann-Kathrin…
AML Treatment Approaches | Factors That Impact Options
https://vimeo.com/825224825 What factors are considered when choosing an AML treatment approach? Dr. Ann-Kathrin Eisfeld explains how shared decision-making comes into play when deciding on a therapy and reviews the options…
Low-Risk Versus High-Risk AML
https://vimeo.com/825225958 How is AML risk determined, and how does it affect treatment options? Dr. Ann-Kathrin Eisfeld defines low-risk and high-risk AML and explains how this classification may predict disease response…
Expert Advice for Navigating AML Treatment and Care Decisions
https://vimeo.com/820984290 AML expert Dr. Ann-Kathrin Eisfeld reviews the importance of essential testing and explains how the results may impact the care and treatment of patients with AML. Dr. Eisfeld also…